Top Core and Group Health Stories
Drugmakers react to legislation easing path for generics
By Dan CookThe CREATES Act has bipartisan support and would ultimately work to lower drug prices, backers say.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
The CREATES Act has bipartisan support and would ultimately work to lower drug prices, backers say.